Last reviewed · How we verify
NCT05121922
Sense of Coherence and Empowerment at Patients With MUPS
NA trial testing Metacognitive Therapy in Medically Unexplained Symptoms in 30 participants. Status unknown.
30 June 2023
Quick facts
| Lead sponsor | University of Oslo |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 30 |
| Start date | 15 August 2021 |
| Primary completion | 30 June 2023 |
| Estimated completion | 30 June 2025 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- Metacognitive Therapy
Conditions studied
- Medically Unexplained Symptoms — all drugs for Medically Unexplained Symptoms →
- Sense of Coherence — all drugs for Sense of Coherence →
Sponsor
University of Oslo
Who can join
18 and older, any sex, with Medically Unexplained Symptoms or Sense of Coherence. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a study on Metacognitive therapy in general practice in Norway. The intervention is a small pilot study to examine whether Metacognitive therapy is feasible in an ordinary general practice. Will the physicians be capable to learn and provide the therapy method for their patients with MUPS and is is possible to implement this in an ordinary general practice routine? Both physicians and their patients will be asked to respond to a questionnaire on perceived utility of the treatment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05121922
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Metacognitive Therapy
Trials testing the same drug.
- NCT06466057 — Metacognitive Therapy for Obsessive-Compulsive Disorder · NA · recruiting
Other recruiting trials for Medically Unexplained Symptoms
Currently open trials in the same condition.
- NCT07007013 — Impact of Humor Prescription on the Emotional Well-being of Patients With Medically Unexplained Symptoms: A Quasi-experi · NA · active not recruiting
- NCT06488547 — Stress and Musculoskeletal Health in Employees · NA · recruiting
Other University of Oslo trials
Trials by the same sponsor.
- NCT07346911 — Digital Interventions for Relapse Prevention in Adolescence · NA · not yet recruiting
- NCT07499219 — Preliminary Testing and Development of a Short Digital Intervention for Patients on Waiting Lists for Psychological Trea · NA · not yet recruiting
- NCT07408687 — Mechanisms Of Change in Psychotherapy: The Effects of Cognitive Behavioral Therapy and Psychodynamic Therapy in Once - V · NA · not yet recruiting
- NCT07287072 — Pain Reprocessing Therapy for Chronic Primary Pain · NA · not yet recruiting
- NCT07428694 — From Bench to Bedside: A Machine Learning Tool for the Detection of Inspiratory Leak · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05121922 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Oslo
- Last refreshed: 9 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05121922.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing